AbbVie Market Cap 2010-2019 | ABBV

AbbVie market cap history and chart from 2010 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AbbVie market cap as of January 21, 2020 is $130.12B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $130.121B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.860B 17.02
Roche Holding AG (RHHBY) Switzerland $290.718B 0.00
Merck (MRK) United States $229.062B 17.75
Pfizer (PFE) United States $223.247B 13.27
Novartis AG (NVS) Switzerland $218.156B 18.41
Novo Nordisk (NVO) Denmark $144.780B 24.95
Eli Lilly (LLY) United States $135.292B 24.98
AstraZeneca (AZN) United Kingdom $133.287B 24.08
Sanofi (SNY) France $125.733B 15.45
GlaxoSmithKline (GSK) United Kingdom $118.475B 14.35
Bristol-Myers Squibb (BMY) United States $109.863B 15.36
Bayer (BAYRY) Germany $78.278B 11.59
H Lundbeck (HLUYY) Denmark $8.258B 14.35